Drug Trial Radar · NCT00804375
Study of the Efficacy, Safety and Tolerability of Topical 2PX (Strontium Chloride Hexahydrate) in Patients With Chronic, Moderate-to-severe Lower Limb Post-amputation Stump Pain
Last checked: Nov 19, 2026Latest source record: Mar 24, 2010 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
150
Planned (sponsor's estimate)
Start
Dec 2008
Primary completion
Jun 2010
Study completion Jun 2010
Sponsor
- Lead sponsor
- Smerud Medical Research International ASAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- SantoSolve AS
- First posted
- Dec 8, 2008
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Primary: To compare the analgesic effect over 12 weeks of topical 2PX in stump pain. Secondary: To prospectively measure other efficacy and safety variables of topical 2PX in stump pain. Exploratory analyses will be performed to measure efficacy and safety variables of topical 2PX in phantom pain
Conditions
- Stump Pain
Interventions
2PXDrug
cutaneous solution to be applied twice daily for 84 days
PlaceboDrug
cutaneous solution to be applied twice daily for 84 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Average (stump) Pain Intensity (AsPI): and recorded in the diary in response to the question: 'What was your average stump pain intensity over the past 24 hours?' on a 100 mm VAS (0 = no pain, 100 = worst pain imaginable).Time frame: will be measured each evening (at least 1 hour after taking off the prosthesis, if applicable, and immediately prior to administering the evening dose of study medication)
Locations
19 sites in 5 countries. Site status is shown where the registry gives one.
Site in Århus
Aarhus, Denmark · Completed
Site in Herlev
Herlev, Denmark · Completed
Site in Hvidovre
Hvidovre, Denmark · Completed
Site in Wiesbaden
Wiesbaden, Germany · Recruiting
Site in Ålesund
Ålesund, Norway · Completed
Site in Hamar
Hamar, Norway · Completed
Site in Oslo
Oslo, Norway · Completed
Site in Stavern
Stavern, Norway · Completed
Site in St. Petersburg
Saint Petersburg, Russia · Recruiting
Site in St.Petersburg
Saint Petersburg, Russia · Recruiting
Site in Belfast
Belfast, United Kingdom · Completed
Site in Birmingham
Birmingham, United Kingdom · Completed
Site in Edinburgh
Edinburgh, United Kingdom · Completed
Site in Glasgow
Glasgow, United Kingdom · Completed
Site in Hammersmith
Hammersmith, United Kingdom · Completed
Site in Crystal Palace
London, United Kingdom · Completed
Site in Manchester
Manchester, United Kingdom · Completed
Site in Middlesborough
Middlesbrough, United Kingdom · Completed
Site in Newcastle
Newcastle, United Kingdom · Completed
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.